These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 35933503)

  • 1. Therapeutic Potential of GLP-2 Analogs in Gastrointestinal Disorders: Current Knowledge, Nutritional Aspects, and Future Perspectives.
    Kounatidis D; Vallianou NG; Tsilingiris D; Christodoulatos GS; Geladari E; Stratigou T; Karampela I; Dalamaga M
    Curr Nutr Rep; 2022 Dec; 11(4):618-642. PubMed ID: 35933503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of glucagon-like peptide 2 in patients with short bowel syndrome: a systematic review and network meta-analysis.
    Sabra HK; Remeih GS; Kereet IM; Hamad M; Ahmed YA; Jahangir K; Bakr MA; Alagelli FA; Sherif H; Elsaid M
    J Gastrointest Surg; 2024 Jul; 28(7):1194-1205. PubMed ID: 38663565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal adaptation and rehabilitation in adults with short bowel syndrome.
    Pironi L
    Curr Opin Clin Nutr Metab Care; 2024 Sep; 27(5):457-461. PubMed ID: 38963563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The indications and results of the use of teduglutide in patients with short bowel.
    El Khatib M; Billiauws L; Joly F
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of short bowel syndrome: Breaking the therapeutic ceiling?
    Wauters L; Joly F
    Nutr Clin Pract; 2023 May; 38 Suppl 1():S76-S87. PubMed ID: 37115030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging drugs for the treatment of short bowel syndrome.
    Frau T; El Khatib M; De Dreuille B; Billiauws L; Nuzzo A; Joly F
    Expert Opin Emerg Drugs; 2024 Sep; 29(3):277-288. PubMed ID: 38761162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of teduglutide in adults with short bowel syndrome-associated intestinal failure.
    Pironi L; Allard JP; Joly F; Geransar P; Genestin E; Pape UF
    Nutr Clin Pract; 2024 Feb; 39(1):141-153. PubMed ID: 37294295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the Pharmacokinetic and Pharmacodynamic Profile of Apraglutide, a Glucagon-Like Peptide-2 Analog, in Healthy Volunteers.
    Bolognani F; Kruithof AC; Schulthess P; Machacek M; de Kam ML; Bergmann KR; van Gent M; Moerland M; Crenn P; Greig G; Gal P
    J Pharmacol Exp Ther; 2023 Aug; 386(2):129-137. PubMed ID: 37316329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.
    Blüthner E; Pape UF; Tacke F; Greif S
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional and medical approaches to intestinal failure.
    Salazar JA; Carey AN; Duggan CP
    Curr Opin Clin Nutr Metab Care; 2023 May; 26(3):201-209. PubMed ID: 37017713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Potential of Biomarkers of Intestinal Barrier Function for Therapeutic Management with Teduglutide in Patients with Short Bowel Syndrome.
    Büttner J; Blüthner E; Greif S; Kühl A; Elezkurtaj S; Ulrich J; Maasberg S; Jochum C; Tacke F; Pape UF
    Nutrients; 2023 Sep; 15(19):. PubMed ID: 37836505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-Marketing Use of Teduglutide in a Large Cohort of Adults with Short Bowel Syndrome-Associated Chronic Intestinal Failure: Evolution and Outcomes.
    de Dreuille B; Nuzzo A; Bataille J; Mailhat C; Billiauws L; Le Gall M; Joly F
    Nutrients; 2023 May; 15(11):. PubMed ID: 37299413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of a Colon-in-Continuity in Short Bowel Syndrome.
    Verbiest A; Jeppesen PB; Joly F; Vanuytsel T
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glepaglutide, a novel glucagon-like peptide-2 agonist, has anti-inflammatory and mucosal regenerative effects in an experimental model of inflammatory bowel disease in rats.
    Skarbaliene J; Mathiesen JM; Larsen BD; Thorkildsen C; Petersen YM
    BMC Gastroenterol; 2023 Mar; 23(1):79. PubMed ID: 36944922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional management of a patient with chronic intestinal failure and hemodialysis receiving teduglutide: A case report.
    Florencio Ojeda L; Domínguez Rabadán R; Laínez López M; Jaldón Hidalgo G; Rodríguez Andrés N; Penco Ramírez C; Rebollo Pérez MI
    Nutrition; 2023 Sep; 113():112137. PubMed ID: 37481817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-acting agonists of human and rodent GLP-2 receptors for studies of the physiology and pharmacological potential of the GLP-2 system.
    Gadgaard S; Windeløv JA; Schiellerup SP; Holst JJ; Hartmann B; Rosenkilde MM
    Biomed Pharmacother; 2023 Apr; 160():114383. PubMed ID: 36780786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and Tolerability of a Single Dose of Apraglutide, a Novel, Long-Acting, Synthetic glucagon-like peptide-2 Analog With a Unique Pharmacologic Profile, in Individuals With Impaired Renal Function.
    Greig G; Youssef NN; Bolognani F
    J Clin Pharmacol; 2024 Jun; 64(6):744-754. PubMed ID: 38465515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expert recommendations on the use of teduglutide in pediatric patients with short bowel syndrome].
    Martínez MI; Balacco M; Busoni V; Fernández A; Rumbo C
    Medicina (B Aires); 2023; 83(1):114-121. PubMed ID: 36774605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing peripubertal growth in a child with short bowel syndrome on full oral feeding with glucagon-like peptide 2 analog.
    Romanchuk A; Bravi M; Tebaldi P; D'Antiga L; Norsa L
    JPGN Rep; 2024 Aug; 5(3):407-410. PubMed ID: 39149188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Teduglutide in the Management of Gastrointestinal Graft-versus-Host Disease in Children and Young Adults.
    Ramos KN; Leino D; Luebbering N; Grimley MS; Badia P; Davies SM; Khandelwal P
    Transplant Cell Ther; 2024 Apr; 30(4):454.e1-454.e6. PubMed ID: 38311212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.